ReleaseWire Connect

Global Atherectomy Devices Market is estimated to value over USD 2.4 Billion by 2029 end and register a CAGR of over 6.5% during the forecast period 2019 to 2029

Automotive 3D Printing Market by Component (Technology, Material, and Services) and Application (Prototyping & Tooling, R&D and Innovation, and Manufacturing Complex Products), by Region - Global Opportunity Analysis and Industry Forecast, 2019-2026

Wrinkle Fillers Market, by Product Type (Biodegradable, Non-biodegradable) by Filler Type (Botulinum Toxin, Soft Tissue Fillers (Collagen), Hyaluronic Acid, Calcium Hydroxyl Apatite, Polylactic Acid, PMMA, Polyalkylimide) by End-User (Hospital, Cosmetic Clinics, Outpatient Centres, Beauty Centre) by Region: Global Opportunity Analysis and Industry Forecast, 2018 - 2026

Cardiac Diagnostic Testing Devices Market, by Product Type (Electrocardiogram (ECG), Echodiogram, Transesophageal Echocardiogram (TEE), Cardiac Catheterization), by End-User (Hospital, Clinics, Diagnostic Laboratories, Long Term Care Centres, Homecare Settings, Ambulatory Surgical Centres, Cath Labs, Emergency Medical Services), by Region: Global Opportunity Analysis and Industry Forecast, 2018 - 2026

High dependency on NSAIDS pain management drugs for pain relief in patients with chronic conditions like cancer, seizures and chronic, increasing dependency on nutritional supplements, rising cases of mental health and related depression treatments, inflammatory conditions in arthritis patients is a burgeoning issue due to related drug-based side effects. Besides the availability of novel OTC drugs that are used with little or no knowledge of how they work is resulting in undesired side effects. An upsurge in the addictive behaviour that including smoking along with alcohol consumption amongst a huge population result in rehabilitation treatments with newer drugs. Also, certain surgical procedures or alternative therapies can adversely affect patients depending on age, gender and disease type. All such elements and known risks associated with legally prescribed drugs potentially call for adverse effects like nausea, drowsiness, dry mouth, birth defects, even death and complications that need hospitalization. Thus drug-based side effects treatment becomes imperative with the help of skilled medical practitioners.

The global resistant depression treatment market is foreseen to value over US$ 1 billion by the endof 2026and register at a CAGR of 3%during the forecast period of 2019-2026. The astounding disclosure of World Health Organisation (WHO) in regards to persistent depressive disorder among young population is indicative of a global need for innovative depression treatment. Innovative because contemporary anxiety and depression treatment medicines remain sterile amongst large patient base as they do not respond or scarcely respond to such medications. With ketamine-based depression treatment being backed up by the Food and Drug Administration (FDA), tremendous innovative opportunities flood the resistant depression treatment market. Resistant Depression Treatment Market Futuristic Opportunities Insight Various market players are striving to harness the benefits of ketamine-based alternative depression treatment. They are focused on launching ground-breaking biopharmaceutical products that can be administered in hospital settings through the medicinal infusion. Besides, researchers at the National Institute of Mental Health, United States continue to verify new compounds like scopolamine in conjunction with non- pharmacological cures like magnetic brain stimulation therapies. Market players with devices that support such non-pharmacological treatments along with useful antidepressant drugs are projected to hold the keys to market dominance in the near future.

Hospital Centralized Monitoring Market by Deployment (On-Premises, Cloud-Based), by End-User (Hospitals, Clinics, Others), by Region: Industry Analysis, Market Share, Revenue Opportunity, Competition and Forecast 2026

Favourable regulatory guidelines for designing and manufacturing of IVT injectables in the interest of patient safety is the primary driving factor for market growth. However, injectables are also associated with multiple risks or complications like inflammation and infection in the eye, vitreous haemorrhage and retinal detachment are expected to restrain the market growth.

Hydrogen Breath Test Analyzer Market by Product Type (Portable Hydrogen Breath Analyzer, Handheld Hydrogen Breath Analyzer), by Sensor Type (Electrochemical Sensor, Solid-State Sensor), by End-User (Hospitals, Pediatric Clinics, Outpatient Centres, Diagnostic Laboratories) and by Region: Global Opportunity Analysis and Industry Forecast, 2019 – 2029

Actinic Keratosis Treatment Market by Treatment Type (Topical Treatment (5-Fluorouracil Cream, Diclofenac Gel, Imiquimod Cream, Ingenol Mebutane Gel), Photodynamic Therapy, Procedural Modality (Chemical Peels, Cryotherapy), by Disease Type (Clinical AK, Sub-clinical AK), by End User (Hospitals, Private Dermatology Clinics, Laser Therapy Centres, Cancer Treatment Centres, Spas and Rejuvenation Centres, Home Care) and by Region: Global Opportunity Analysis and Industry Forecast, 2019 -2029